Newfeed

COLUMBUS, Ohio, Feb. 28, 2024 /PRNewswire/ — Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has been selected to manufacture adeno-associated vectors (AAV) therapies in its suspension platform for s

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: